Sherman Chang is an accomplished professional in the field of research and development, currently serving as Senior VP of R&D at SOLVD Health since April 2024. Prior to this role, Sherman held the position of VP of R&D at SOLVD Health (formerly AutoGenomics) for over eight years, focusing on research in Pharmacogenetics, Oncology/Cancer, Women’s Health, and Infectious Diseases. Experience includes significant roles at AutoGenomics and Proove Biosciences, where Sherman developed clinical development plans, managed clinical data systems, and supported commercial efforts. Earlier career roles include Senior Director at DermTech International, where Sherman led R&D projects and budgeting, and positions at Diversa and Torrey Mesa Research Institute, concentrating on enzyme-based product development and GeneChip microarray projects, respectively. Sherman earned a Ph.D. in Molecular Biology from the University of Pittsburgh.